Evidence map›Paper›PMID 36582811›Full record

ArticleJournal of diabetes research2022

Burden of Diabetes Mellitus in Nepal: An Analysis of Global Burden of Disease Study 2019.

Achyut Raj Pandey, Krishna Kumar Aryal, Niraj Shrestha, Dikshya Sharma, Jasmine Maskey, Meghnath Dhimal

Abstract read
In one paragraph

Article in Journal of diabetes research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Protective Effects of Isolated Curcumin FromJournal of diabetes research · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Phytochemicals Characterization and Antidiabetic Efficacy ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Achyut Raj PandeyHERD International, Kathmandu, Nepal.ORCID https://orcid.org/0000-0002-1037-1273
Krishna Kumar AryalPublic Health Promotion and Development Organization, Kathmandu, Nepal.ORCID https://orcid.org/0000-0003-0801-0775
Niraj ShresthaAbt Britain, Kathmandu, Nepal.ORCID https://orcid.org/0000-0002-6741-0384
Dikshya SharmaSambhav (Possible), Kathmandu, Nepal.ORCID https://orcid.org/0000-0002-4221-6286
Jasmine MaskeyOxford University Clinical Research Unit, Lalitpur, Nepal.ORCID https://orcid.org/0000-0001-7324-4151
Meghnath DhimalNepal Health Research Council, Kathmandu, Nepal.ORCID https://orcid.org/0000-0001-7176-7821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, the number of people living with diabetes mellitus (DM) increased by 62% between 1990 and 2019, affecting 463 million people in 2019, and is projected to increase further by 51% by 2045. The increasing burden of DM that requires chronic care could have a considerable cost implication in the health system, particularly in resource constraint settings like Nepal. In this context, this study attempts to present the burden of DM in terms of prevalence, mortality, and disability adjusted life years (DALYs). The study is based on the Global Burden of Disease Study 2019, a multinational collaborative research, led by the Institute for Health Metrics and Evaluations. In the study, the overall prevalence of DM was estimated using DisMod MR-2.1, a Bayesian metaregression model. DALYs were estimated summing years of life lost due to premature death and years lived with disability. There were a total of 1,412,180 prevalent cases of DM, 3,474 deaths and 189,727 DALYs, due to DM in 2019. All-age prevalence rate and the age-standardized prevalence rate of DM stood at 4,642.83 (95% uncertainty interval (UI): 4,178.58-5,137.74) and 5,735.58 (95% UI: 5,168.74-6327.73) cases per 100,000 population, respectively, in 2019. In 2019, 1.8% (95% UI: 1.54, 2.07) of total deaths were from DM, which is a more than three-fold increase from the proportion of deaths attributed in 1990 (0.43%, 95% UI: 0.36, 0.5) with most of these deaths being from DM type 2. In 2019, a total of 189,727 disability adjusted life years (DALYs) were attributable to DM of which 105,950 DALYs were among males, and the remaining 83,777 DALYs were among females. Overall, between 1990 and 2019, the DALYs, attributable to Type 1 and 2 DM combined and for Type 2 DM only, have increased gradually across both sexes. However, the DALYs per 100,000 attributable to DM have slightly reduced across both sexes in that time. There is a high burden of DM in Nepal in 2019 with a steep increase in the proportion of deaths attributable to DM in Nepal which could pose a serious challenge to the health system. Primary prevention of DM requires collaborative efforts from multiple sectors. Meanwhile, the current federal structure could be an opportunity for integrated, locally tailored public health and clinical interventions for the prevention of the disease and its consequences.

Indexed as

Diabetes Mellitus, Type 2Global Burden of DiseaseBayes TheoremFemaleHumansMaleNepalPrevalenceQuality-Adjusted Life Years

Identifiers

PMID36582811
PMCPMC9794432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.